Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Dec;16(12):e013199.
doi: 10.1161/CIRCINTERVENTIONS.123.013199. Epub 2023 Nov 13.

Efficacy and User Experience of a Novel X-Ray Shield on Operator Radiation Exposure During Cardiac Catheterization: A Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Efficacy and User Experience of a Novel X-Ray Shield on Operator Radiation Exposure During Cardiac Catheterization: A Randomized Controlled Trial

Cedric Davidsen et al. Circ Cardiovasc Interv. 2023 Dec.

Abstract

Background: Radiation shielding is mandatory during cardiac catheterization, but there is a need to improve efficacy and ease of use.

Methods: The aim of the study was to assess the shielding effect and user feedback for a novel flexible multiconfiguration x-ray shield (FMX). The 0.5-mm Pb equivalent FMX can be selectively configured to accommodate for variations in patient morphology, access site, and type of procedure with maintained visualization, vascular access, and shielding. To evaluate efficacy, relative operator dose (operator dose indexed for given dose) was measured during 103 consecutive procedures randomized in a 1:1 proportion to the current routine setup or FMX+routine. User feedback was collected on function, relevance, and likelihood of adoption into clinical practice.

Results: Median relative operator dose was 3.63 μSv/µGy·m2×10-3 (IQR, 2.62-6.37) with routine setup and 0.57 μSv/µGy·m2×10-3 (IQR, 0.27-1.06) with FMX+routine, which amounts to an 84.4% reduction (P<0.001). For 500 procedures/year, this corresponds to an estimated yearly dose reduction from 3.6 to 0.7 mSv. User feedback regarding size, functionality, ease of use, likely to use, critical issues, shielding, draping, procedure time, vascular access, patient discomfort, and risk was 99% positive. No critical issues were identified. There was no significant difference in patient radiation exposure.

Conclusions: The FMX reduces radiation exposure considerably. The FMX represents an effective and attractive solution for radiation protection that can easily be implemented in existing workflow. FMX has potential for general use with maintained visualization, vascular access, and shielding in routine cardiac catheterization.

Keywords: cardiac catheterization; fluoroscopy; patient; radiation exposure; radiation protection.

PubMed Disclaimer

Conflict of interest statement

Disclosures Drs Tuseth and Davidsen are co-inventors in a patent pending on x-ray shield design. The other authors report no conflicts.

Figures

Figure 1.
Figure 1.
Scatter radiation and mechanism of action of the flexible x-ray shield. A, Illustration of unshielded scatter radiation from the patient in a routine shielding setup using photons from the visible part of the electromagnetic spectrum. B, The flexible x-ray shield seals the gaps between the ceiling- and table-mounted shield thus enhancing operator protection.
Figure 2.
Figure 2.
Illustration of the novel flexible multiconfiguration x-ray shield. The versatile design can adopt multiple configurations to accommodate variations in patient morphology, access site, and type of procedure. A, Combined radial and femoral access. B, Double femoral access. C, Left radial vascular access with the flap in open position.
Figure 3.
Figure 3.
Relative operator dose (ROD) according to shielding setup. Adding the flexible multiconfiguration x-ray shield (FMX) resulted in a median reduction of 84.4% of ROD (P<0.001) across all procedures (A). It was similarly effective in both intracoronary procedures (B) and during coronary angiographies (C).
Figure 4.
Figure 4.
User feedback on functionality and user-friendliness. Participating operators answered a feedback form with 11 questions and 3 grading options (optimal, adequate, and should be improved). About 86% of feedback was optimal, 13% adequate, 1% should be improved. No critical issues were identified.

Comment in

References

    1. Elmaraezy A, Ebraheem Morra M, Tarek Mohammed A, Al-Habaa A, Elgebaly A, Abdelmotaleb Ghazy A, Khalil AM, Tien Huy N, Hirayama K. Risk of cataract among interventional cardiologists and catheterization lab staff: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2017;90:1–9. doi: 10.1002/ccd.27114 - PubMed
    1. Andreassi MG, Piccaluga E, Guagliumi G, Del Greco M, Gaita F, Picano E. Occupational health risks in cardiac catheterization laboratory workers. Circ Cardiovasc Interv. 2016;9:e003273. doi: 10.1161/CIRCINTERVENTIONS.115.003273 - PubMed
    1. Roguin A, Goldstein J, Bar O, Goldstein JA. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol. 2013;111:1368–1372. doi: 10.1016/j.amjcard.2012.12.060 - PubMed
    1. Yong CM, Abnousi F, Rzeszut AK, Douglas PS, Harrington RA, Mehran R, Grines C, Altin SE, Duvernoy CS; American College of Cardiology Women in Cardiology Leadership Council (ACC WIC). Sex differences in the pursuit of interventional cardiology as a subspecialty among cardiovascular fellows-in-training. JACC Cardiovasc Interv. 2019;12:219–228. doi: 10.1016/j.jcin.2018.09.036 - PubMed
    1. McCutcheon K, Vanhaverbeke M, Pauwels R, Dabin J, Schoonjans W, Bennett J, Adriaenssens T, Dubois C, Sinnaeve P, Desmet W. Efficacy of MAVIG X-ray protective drapes in reducing operator radiation dose in the cardiac catheterization laboratory: a randomized controlled trial. Circ Cardiovasc Interv. 2020;13:e009627. doi: 10.1161/CIRCINTERVENTIONS.120.009627 - PubMed

Publication types

MeSH terms